REVIEW
Optimal medication for tumors modeled by a Cahn-Hilliard-Brinkman equation
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
Signed reviews
read the original abstract
In this paper, we study a distributed optimal control problem for a diffuse interface model for tumor growth. The model consists of a Cahn-Hilliard type equation for the phase field variable coupled to a reaction diffusion equation for the nutrient and a Brinkman type equation for the velocity. The system is equipped with homogeneous Neumann boundary conditions for the tumor variable and the chemical potential, Robin boundary conditions for the nutrient and a "no-friction" boundary condition for the velocity. The control acts as a medication by cytotoxic drugs and enters the phase field equation. The cost functional is of standard tracking type and is designed to track the variables of the state equation during the evolution and the distribution of tumor cells at some fixed final time. We prove that the model satisfies the basics for calculus of variations and we establish first-order necessary optimality conditions for the optimal control problem.
Discussion (0). Continue with ORCID to comment.